BridgeHealth Pharmaceuticals raises $3.5M in November 2026 SEC filing
BridgeHealth Pharmaceuticals
- Raised in SEC filings
- $3.5M
- Filings
- 1
- Latest est. round
- Seed
- Incorporated
- 2025
- Industry
- Pharmaceuticals
- Based in
- MA
BridgeHealth Pharmaceuticals filed its first SEC Form D in November 2026. This filing reported an estimated seed round of $3.5 million, with the first sale occurring on October 22, 2026. All rounds are estimates.
The latest filing names Neal Muni and Indu Muni as executive officers and directors, with Howard Ackerman also listed as a director. BridgeHealth Pharmaceuticals was incorporated in 2025 and is based in Massachusetts, operating in the pharmaceuticals industry. We do not track its open roles yet.
Every Form D filing
| First sale | Amount sold | Est. round |
|---|---|---|
| 2026-10-22 | $3.5M | Seed |
Named in the latest filing
- Neal Muni
- Indu Muni
- Howard Ackerman
From SEC Form D filings. Rounds are our estimate from the amount sold; filings carry no valuation. All filings on SEC EDGAR